Keyphrases
Hailey-Hailey Disease
100%
Apremilast
100%
Review of Reported Cases
100%
Targeted Therapy
56%
Targeted Immunotherapy
56%
Sentinel Node Metastasis
50%
Completion Lymph Node Dissection
50%
PTPRD
50%
Point mutation
50%
Single Institution
50%
Melanoma
50%
Japanese Patients
50%
Cancer Hospital
50%
Metastatic Melanoma
50%
Carcinoma Cells
50%
Protein Stability
50%
Burn Scar
50%
Extracellular Domain
50%
Basal Cell Carcinoma
50%
Cancer-related
50%
Heparan Sulfate Proteoglycans
50%
Survey in Japan
50%
Squamous Cell Carcinoma (SqCC)
50%
Dermatologist
50%
Median Overall Survival
44%
Skin Diseases
33%
Overall Survival
32%
Skin Lesions
28%
Best Response
28%
Headache
28%
Tumor
28%
Dermatology Consultation
25%
Protein Tyrosine Phosphatase 1B (PTP1B)
25%
Phosphatase Activity
25%
In Cancer
25%
Chemotherapy
25%
Therapeutic Potential
24%
Temple
21%
Squamous Carcinoma Cells
21%
New Therapies
20%
Overall Survival Benefit
20%
Lymph Node Positive
18%
Sentinel Lymph Node
18%
Malignant Wounds
16%
Transmembrane Segment
16%
Wound Management
16%
Immunoglobulin Domain
16%
Continuation Treatment
16%
Cancer Treatment
16%
Protein Expression
16%
Medicine and Dentistry
Hailey-Hailey Disease
100%
Apremilast
100%
Overall Survival
75%
Malignant Neoplasm
62%
Melanoma
57%
Targeted Therapy
56%
Immunotherapy
56%
Consultation
56%
Metastatic Carcinoma
50%
Metastatic Melanoma
50%
Sentinel Node
50%
Retroperitoneal Lymph Node Dissection
50%
Squamous Cell Carcinoma
50%
Burn Scar
50%
Basal Cell Carcinoma Cell
50%
Dermatosis
35%
Adverse Event
35%
Antibiotics
28%
Headache
28%
Skin Defect
28%
Chemotherapy
28%
Neoplasm
25%
Basal-Cell Carcinoma
25%
Dermatology
21%
Sentinel Lymph Node
18%
Recurrent Disease
18%
Squamous Cell Carcinoma Cell
18%
Wound Management
14%
Disease
14%
Cancer Therapy
14%
Genetic Analysis
14%
Topical Corticosteroid
14%
Autosomal Dominant Inheritance
14%
Genetic Disorder
14%
Cyclosporine
14%
Disease Severity
14%
Myalgia
14%
Anticarcinogen
12%
Skin Cancer
12%
Keratinocyte
12%
Quality of Life
7%
Patient Compliance
7%
Cancer Treatment
7%
Skin Tumor
7%
Gastrointestinal Cancer
7%
Primary Tumor
7%
Subgroup Analysis
7%
Stem Cell Transplant
7%
Skin Infection
7%
Survival Time
7%